Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats

Maria Alicia Carrillo-Sepulveda, Kathryn Spitler, Deepesh Pandey, Dan E Berkowitz, Takayuki Matsumoto

Research output: Contribution to journalArticle

Abstract

Abstract: Hyperglycemia-induced reactive oxygen species (ROS) production plays a major role in the pathogenesis of diabetic vascular dysfunction. However, the underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a key component of innate immunity, is known to be activated during diabetes. Therefore, we hypothesize that hyperglycemia activates TLR4 signaling in vascular smooth muscle cells (VSMCs) that triggers ROS production and causes vascular dysfunction. Rat mesenteric VSMCs exposed to high glucose (25 mmol/l) increased TLR4 expression and activated TLR4 signaling via upregulation of myeloid differentiation factor 88 (MyD88). TLR4 inhibitor CLI-095 significantly attenuated elevated levels of ROS and nuclear factor-kappa B (NF-κB) activity in VSMCs exposed to high glucose. Mesenteric arteries from streptozotocin-induced diabetic rats treated with CLI-095 (2 mg/kg/day) intraperitoneally for 2 weeks exhibited reduced ROS generation and attenuated noradrenaline-induced contraction. These results suggest that hyperglycemia-induced ROS generation and NF-κB activation in VSMCs are at least, in part, mediated by TLR4 signaling. Therefore, strategies to block TLR4 signaling pathways pose a promising avenue to alleviate diabetic-induced vascular complications. Key messages: High glucose-induced TLR4 activation in vascular smooth muscle cells.Inhibition of TLR4 attenuated high glucose-induced ROS production and NF-κB activity in VSMC.Suppression of TLR4 signaling attenuated mesenteric contraction in diabetic rat.

Original languageEnglish (US)
Pages (from-to)1341-1354
Number of pages14
JournalJournal of Molecular Medicine
Volume93
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Toll-Like Receptor 4
Blood Vessels
Oxidative Stress
Vascular Smooth Muscle
Smooth Muscle Myocytes
Reactive Oxygen Species
NF-kappa B
Hyperglycemia
Glucose
Myeloid Differentiation Factor 88
Diabetic Angiopathies
Mesenteric Arteries
Streptozocin
Innate Immunity
Norepinephrine
Up-Regulation

Keywords

  • Diabetes
  • High glucose
  • NF-κB
  • ROS
  • TLR4
  • Vascular smooth muscle cell

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery
  • Genetics(clinical)

Cite this

Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats. / Carrillo-Sepulveda, Maria Alicia; Spitler, Kathryn; Pandey, Deepesh; Berkowitz, Dan E; Matsumoto, Takayuki.

In: Journal of Molecular Medicine, Vol. 93, No. 12, 01.12.2015, p. 1341-1354.

Research output: Contribution to journalArticle

Carrillo-Sepulveda, Maria Alicia ; Spitler, Kathryn ; Pandey, Deepesh ; Berkowitz, Dan E ; Matsumoto, Takayuki. / Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats. In: Journal of Molecular Medicine. 2015 ; Vol. 93, No. 12. pp. 1341-1354.
@article{e12c639d12324ea7891bdb1750a03481,
title = "Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats",
abstract = "Abstract: Hyperglycemia-induced reactive oxygen species (ROS) production plays a major role in the pathogenesis of diabetic vascular dysfunction. However, the underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a key component of innate immunity, is known to be activated during diabetes. Therefore, we hypothesize that hyperglycemia activates TLR4 signaling in vascular smooth muscle cells (VSMCs) that triggers ROS production and causes vascular dysfunction. Rat mesenteric VSMCs exposed to high glucose (25 mmol/l) increased TLR4 expression and activated TLR4 signaling via upregulation of myeloid differentiation factor 88 (MyD88). TLR4 inhibitor CLI-095 significantly attenuated elevated levels of ROS and nuclear factor-kappa B (NF-κB) activity in VSMCs exposed to high glucose. Mesenteric arteries from streptozotocin-induced diabetic rats treated with CLI-095 (2 mg/kg/day) intraperitoneally for 2 weeks exhibited reduced ROS generation and attenuated noradrenaline-induced contraction. These results suggest that hyperglycemia-induced ROS generation and NF-κB activation in VSMCs are at least, in part, mediated by TLR4 signaling. Therefore, strategies to block TLR4 signaling pathways pose a promising avenue to alleviate diabetic-induced vascular complications. Key messages: High glucose-induced TLR4 activation in vascular smooth muscle cells.Inhibition of TLR4 attenuated high glucose-induced ROS production and NF-κB activity in VSMC.Suppression of TLR4 signaling attenuated mesenteric contraction in diabetic rat.",
keywords = "Diabetes, High glucose, NF-κB, ROS, TLR4, Vascular smooth muscle cell",
author = "Carrillo-Sepulveda, {Maria Alicia} and Kathryn Spitler and Deepesh Pandey and Berkowitz, {Dan E} and Takayuki Matsumoto",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s00109-015-1318-7",
language = "English (US)",
volume = "93",
pages = "1341--1354",
journal = "Journal of Molecular Medicine",
issn = "0946-2716",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Inhibition of TLR4 attenuates vascular dysfunction and oxidative stress in diabetic rats

AU - Carrillo-Sepulveda, Maria Alicia

AU - Spitler, Kathryn

AU - Pandey, Deepesh

AU - Berkowitz, Dan E

AU - Matsumoto, Takayuki

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Abstract: Hyperglycemia-induced reactive oxygen species (ROS) production plays a major role in the pathogenesis of diabetic vascular dysfunction. However, the underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a key component of innate immunity, is known to be activated during diabetes. Therefore, we hypothesize that hyperglycemia activates TLR4 signaling in vascular smooth muscle cells (VSMCs) that triggers ROS production and causes vascular dysfunction. Rat mesenteric VSMCs exposed to high glucose (25 mmol/l) increased TLR4 expression and activated TLR4 signaling via upregulation of myeloid differentiation factor 88 (MyD88). TLR4 inhibitor CLI-095 significantly attenuated elevated levels of ROS and nuclear factor-kappa B (NF-κB) activity in VSMCs exposed to high glucose. Mesenteric arteries from streptozotocin-induced diabetic rats treated with CLI-095 (2 mg/kg/day) intraperitoneally for 2 weeks exhibited reduced ROS generation and attenuated noradrenaline-induced contraction. These results suggest that hyperglycemia-induced ROS generation and NF-κB activation in VSMCs are at least, in part, mediated by TLR4 signaling. Therefore, strategies to block TLR4 signaling pathways pose a promising avenue to alleviate diabetic-induced vascular complications. Key messages: High glucose-induced TLR4 activation in vascular smooth muscle cells.Inhibition of TLR4 attenuated high glucose-induced ROS production and NF-κB activity in VSMC.Suppression of TLR4 signaling attenuated mesenteric contraction in diabetic rat.

AB - Abstract: Hyperglycemia-induced reactive oxygen species (ROS) production plays a major role in the pathogenesis of diabetic vascular dysfunction. However, the underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a key component of innate immunity, is known to be activated during diabetes. Therefore, we hypothesize that hyperglycemia activates TLR4 signaling in vascular smooth muscle cells (VSMCs) that triggers ROS production and causes vascular dysfunction. Rat mesenteric VSMCs exposed to high glucose (25 mmol/l) increased TLR4 expression and activated TLR4 signaling via upregulation of myeloid differentiation factor 88 (MyD88). TLR4 inhibitor CLI-095 significantly attenuated elevated levels of ROS and nuclear factor-kappa B (NF-κB) activity in VSMCs exposed to high glucose. Mesenteric arteries from streptozotocin-induced diabetic rats treated with CLI-095 (2 mg/kg/day) intraperitoneally for 2 weeks exhibited reduced ROS generation and attenuated noradrenaline-induced contraction. These results suggest that hyperglycemia-induced ROS generation and NF-κB activation in VSMCs are at least, in part, mediated by TLR4 signaling. Therefore, strategies to block TLR4 signaling pathways pose a promising avenue to alleviate diabetic-induced vascular complications. Key messages: High glucose-induced TLR4 activation in vascular smooth muscle cells.Inhibition of TLR4 attenuated high glucose-induced ROS production and NF-κB activity in VSMC.Suppression of TLR4 signaling attenuated mesenteric contraction in diabetic rat.

KW - Diabetes

KW - High glucose

KW - NF-κB

KW - ROS

KW - TLR4

KW - Vascular smooth muscle cell

UR - http://www.scopus.com/inward/record.url?scp=84948571469&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948571469&partnerID=8YFLogxK

U2 - 10.1007/s00109-015-1318-7

DO - 10.1007/s00109-015-1318-7

M3 - Article

C2 - 26184970

AN - SCOPUS:84948571469

VL - 93

SP - 1341

EP - 1354

JO - Journal of Molecular Medicine

JF - Journal of Molecular Medicine

SN - 0946-2716

IS - 12

ER -